Clinically isolated syndrome

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune, humanized) 1 substance
Phase IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

1 trial
  • F. Hoffmann-La Roche AG Commercial
    OCRELIZUMAB
    2024-510974-25-00 2 countries 2021 n=10
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
F. Hoffmann-La Roche AG Commercial 1 Phase IV 0
New trials by year
2021
1
← All indication landscapes